Development and Validation of a Highly Multiplexed Immunohistochemistry Panel for Use as a Risk Stratification Tool for High-Risk Non-Muscle Invasive Bladder Cancer

Dr. Meeks will oversee all aspects of the projects that involve whole exome sequencing. He will be responsible for managing all research and training activities, including the execution of experiments and supervision of laboratory staff. He will work with his partnering PIs to ensure the research is carried out in a responsible manner, and disseminate his findings at a meeting with colleagues.